Filing Details
- Accession Number:
- 0001181431-11-037199
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-17 11:08:12
- Reporting Period:
- 2011-06-15
- Filing Date:
- 2011-06-17
- Accepted Time:
- 2011-06-17 11:08:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1400431 | Patheon Inc | PTI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286396 | Michael Lytton | 4721 Emperor Blvd Suite 200 Durham NC 27703 | Evp Corporate Development & St | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Voting Shares | Acquisiton | 2011-06-15 | 27,700 | $2.04 | 27,700 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Restricted Voting Shares | Employee Stock Option (right to buy) | Acquisiton | 2011-06-15 | 400,000 | $0.00 | 400,000 | $2.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 400,000 | 2021-06-15 | No | 4 | A | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.01 to $2.04, inclusive. The reporting person undertakes to provide to Patheon Inc., any security holder of Patheon Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1). The amounts reported in column 4 and this footnote (1) were converted from Canadian dollars into U.S. dollars based on the June 15, 2011 closing exchange rate of 0.9790 Canadian dollars per U.S. dollar as quoted by Reuters.
- The exercise price was converted from C$2.09 based on the June 15, 2011 closing exchange rate of 0.9790 Canadian dollars per U.S. dollar as quoted by Reuters. The actual exercise price will be the Canadian dollar amount regardless of the exchange rate on the date of grant or of exercise.
- The option vests in five equal annual installments on June 15, 2012, June 15, 2013, June 15, 2014, June 15, 2015, and June 15, 2016.
Billionaire Hedge Funds
